Cargando…
Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma
BACKGROUND: Tumor mutation burden (TMB) as estimated by cancer gene panels (CGPs) has been confirmed to be associated with prognosis and is effective in predicting clinical benefit from immune checkpoint blockade (ICB) in solid tumors. However, whether the TMB calculated by CGPs is associated with o...
Autores principales: | Chen, Cunte, Liu, Sichu, Jiang, Xinmiao, Huang, Ling, Chen, Feili, Wei, Xiaojun, Guo, Hanguo, Shao, Yang, Li, Yangqiu, Li, Wenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962318/ https://www.ncbi.nlm.nih.gov/pubmed/33722306 http://dx.doi.org/10.1186/s40164-021-00215-4 |
Ejemplares similares
-
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2021) -
Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population
por: Chen, Feili, et al.
Publicado: (2020) -
Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use
por: Chen, Feili, et al.
Publicado: (2020) -
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2022) -
TNFAIP3
mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia
por: Chen, Cunte, et al.
Publicado: (2022)